Cargando…

BDNF as a Promising Therapeutic Agent in Parkinson’s Disease

Brain-derived neurotrophic factor (BDNF) promotes neuroprotection and neuroregeneration. In animal models of Parkinson’s disease (PD), BDNF enhances the survival of dopaminergic neurons, improves dopaminergic neurotransmission and motor performance. Pharmacological therapies of PD are symptom-target...

Descripción completa

Detalles Bibliográficos
Autores principales:	Palasz, Ewelina, Wysocka, Adrianna, Gasiorowska, Anna, Chalimoniuk, Malgorzata, Niewiadomski, Wiktor, Niewiadomska, Grazyna
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7037114/ https://www.ncbi.nlm.nih.gov/pubmed/32050617 http://dx.doi.org/10.3390/ijms21031170

Ejemplares similares

Exercise-Induced Neuroprotection and Recovery of Motor Function in Animal Models of Parkinson's Disease
por: Palasz, Ewelina, et al.
Publicado: (2019)

Neuroplasticity and Neuroprotective Effect of Treadmill Training in the Chronic Mouse Model of Parkinson's Disease
por: Palasz, Ewelina, et al.
Publicado: (2019)

Tau Oligomers Neurotoxicity
por: Niewiadomska, Grazyna, et al.
Publicado: (2021)

Dangerous Liaisons: Tau Interaction with Muscarinic Receptors
por: Wysocka, Adrianna, et al.
Publicado: (2020)

The Biology and Pathobiology of Glutamatergic, Cholinergic, and Dopaminergic Signaling in the Aging Brain
por: Gasiorowska, Anna, et al.
Publicado: (2021)

Cholinergic and inflammatory phenotypes in transgenic tau mouse models of Alzheimer’s disease and frontotemporal lobar degeneration
por: Cranston, Anna L, et al.
Publicado: (2020)

TracMouse: A computer aided movement analysis script for the mouse inverted horizontal grid test
por: Niewiadomski, W., et al.
Publicado: (2016)

Exaggerated pressor response to static squats in Parkinson’s disease (PD) and healthy subjects is likely an individual trait, not influenced by whole body vibration (WBV)
por: Niewiadomski, Wiktor, et al.
Publicado: (2023)

Role of Mitogen Activated Protein Kinase Signaling in Parkinson’s Disease
por: Bohush, Anastasiia, et al.
Publicado: (2018)

Device for Controlling Stimulus Self-Application During Autonomic Nervous System Tests
por: Żyliński, Marek, et al.
Publicado: (2021)

Regulation of BDNF-TrkB Signaling and Potential Therapeutic Strategies for Parkinson’s Disease
por: Jin, Wook
Publicado: (2020)

The Promise of Neuroprotective Agents in Parkinson’s Disease
por: Seidl, Stacey E., et al.
Publicado: (2011)

The Effect of Endurance Training on Brain-Derived Neurotrophic Factor and Inflammatory Markers in Healthy People and Parkinson's Disease. A Narrative Review
por: Małczyńska-Sims, Paulina, et al.
Publicado: (2020)

High-intensity interval training modulates inflammatory response in Parkinson’s disease
por: Malczynska-Sims, Paulina, et al.
Publicado: (2022)

Erratum: The promise of neuroprotective agents in Parkinson's disease
por: Seidl, Stacey E., et al.
Publicado: (2013)

Correction: High-intensity interval training modulates inflammatory response in Parkinson’s disease
por: Malczynska-Sims, Paulina, et al.
Publicado: (2022)

Promising drug targets and associated therapeutic interventions in Parkinson’s disease
por: Rai, Sachchida Nand, et al.
Publicado: (2021)

Exercise-Induced Elevated BDNF Level Does Not Prevent Cognitive Impairment Due to Acute Exposure to Moderate Hypoxia in Well-Trained Athletes
por: Piotrowicz, Zofia, et al.
Publicado: (2020)

Gene polymorphisms and motor levodopa‐induced complications in Parkinson's disease
por: Michałowska, Małgorzata, et al.
Publicado: (2020)

Current Disease-Targets for Oleocanthal as Promising Natural Therapeutic Agent
por: Segura-Carretero, Antonio, et al.
Publicado: (2018)

Molecular hydrogen is a promising therapeutic agent for pulmonary disease
por: FU, Zhiling, et al.
Publicado: (2022)

The Promise and Challenges of Developing miRNA-Based Therapeutics for Parkinson’s Disease
por: Titze-de-Almeida, Simoneide S., et al.
Publicado: (2020)

HSP90 and Its Novel Co-Chaperones, SGT1 and CHP-1, in Brain of Patients with Parkinson’s Disease and Dementia with Lewy Bodies
por: Bohush, Anastasiia, et al.
Publicado: (2019)

The Impact of Acute Mild Normobaric Hypoxia and a Single Bout of Exercise to Volitional Exhaustion on Cognitive Performance in Endurance and Strength-Trained Athletes: The role of BDNF, EP-1, Catecholamines and Lactate
por: Piotrowicz, Zofia, et al.
Publicado: (2023)

Acute normobaric hypoxia does not affect the simultaneous exercise-induced increase in circulating BDNF and GDNF in young healthy men: A feasibility study
por: Piotrowicz, Zofia, et al.
Publicado: (2019)

Immunomodulators as Therapeutic Agents in Mitigating the Progression of Parkinson’s Disease
por: Grimmig, Bethany, et al.
Publicado: (2016)

Therapeutic potential of autophagy-enhancing agents in Parkinson’s disease
por: Moors, Tim E., et al.
Publicado: (2017)

A promising connection between BDNF and Alzheimer’s disease
por: Giuffrida, Maria Laura, et al.
Publicado: (2018)

BDNF: A Key Factor with Multipotent Impact on Brain Signaling and Synaptic Plasticity
por: Kowiański, Przemysław, et al.
Publicado: (2017)

Early hemodynamic response to the tilt test in patients with syncope
por: Koźluk, Edward, et al.
Publicado: (2014)

Curcumin Nanoparticles as Promising Therapeutic Agents for Drug Targets
por: Chopra, Hitesh, et al.
Publicado: (2021)

Potential Therapeutic Targets and Promising Agents for Combating NAFLD
por: Umemura, Atsushi, et al.
Publicado: (2022)

Diagnostic and therapeutic agents that target alpha-synuclein in Parkinson’s disease
por: Nwabufo, Chukwunonso K., et al.
Publicado: (2022)

Nanophytomedicines as Therapeutic Agents for Parkinson’s Disease
por: Burns, Jessica, et al.
Publicado: (2023)

Assessment of Risk Hospitalization due to Acute Respiratory Incidents Related to Ozone Exposure in Silesian Voivodeship (Poland)
por: Niewiadomska, Ewa, et al.
Publicado: (2020)

The Influence of Electroconvulsive Therapy (ECT) on Brain-Derived Neurotrophic Factor (BDNF) Plasma Level in Patients with Schizophrenia—A Systematic Review and Meta-Analysis
por: Szota, Anna Maria, et al.
Publicado: (2023)

BDNF Therapeutic Mechanisms in Neuropsychiatric Disorders
por: Bazzari, Amjad H., et al.
Publicado: (2022)

Highlights of ASS234: a novel and promising therapeutic agent for Alzheimer’s disease therapy
por: Romero, Alejandro, et al.
Publicado: (2019)

MPTP-induced mouse model of Parkinson’s disease: A promising direction for therapeutic strategies
por: Mustapha, Musa, et al.
Publicado: (2021)

Bilirubin: A Promising Therapy for Parkinson’s Disease
por: Jayanti, Sri, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_3fgeokj6fjh3h0mj8jsi001ies